Epidemiology of Malignant Melanoma

  • J. A. H. Lee


The melanomas occur at a variety of anatomical sites, different phenotypes and genotypes strongly influence their incidence, and they have recognizable precursor lesions. All of this Variation presents opportunities for fruitful comparisons. As a result, in a high risk population known factors can account for perhaps half the cases (English and Armstrong 1988). This is about the same as the proportion for female breast cancer (Bruzzi et al. 1985). Yet the epidemiology of melanoma is loaded with paradox. Generalizations, if they can be offered at all, are hedged with exceptions. New data, for example the finding that in a high risk population, small melanomas were not associated with the usual host factors (Schneider et al. 1987), often do not fit in.


Female Breast Cancer Skin Melanoma Melanoma Risk Melanoma Incidence Sunny Place 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C (1985) Estimating the population attributable risk for multiple risk factors using case control data. Am J Epidemiol 122: 904–914PubMedGoogle Scholar
  2. Cicerone RJ (1987) Changes in stratospheric ozone. Science 237: 35–42PubMedCrossRefGoogle Scholar
  3. Drzewiecki KT, Frydman H, Andersen PK, Poulsen H, Ladefoged C, Vibe P (1990) Malignant melanoma. Changing trends in factors influencing metastasis-free survival from 1964 to 1982. Cancer 65: 362–366PubMedCrossRefGoogle Scholar
  4. English DR, Armstrong BK (1988) Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia. Br Med J 296: 1285–1288CrossRefGoogle Scholar
  5. Evans RD, Kopf AW, Lew RA et al. (1988) Risk factors for the development of malignant melanoma- 1: Review of case-control studies. Dermatol Surg Oncol 14: 393–408Google Scholar
  6. Frederick JE, Snell HE, Haywood EK (1989) Solar ultraviolet radiation at the earth’s surface. Photochem Photobiol 50: 443–450CrossRefGoogle Scholar
  7. Gallagher RP, Elwood JM, Threlfall WJ et al. (1987) Socioeconomic status, sunlight exposure, and risk of malignant melanoma: the Western Canada Melanoma Study. J Natl Cancer Inst 79: 647–652PubMedGoogle Scholar
  8. Gallagher RP, Elwood JM, Yang CP (1989) Is chronic sunlight exposure important in accounting for increases in melanoma incidence? Int J Cancer 44: 813–815PubMedCrossRefGoogle Scholar
  9. Gallagher RP, Ma B, McLean DI et al. (1990) Trends in basal cell Carcinoma, squamous cell Carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol 23: 413–421PubMedCrossRefGoogle Scholar
  10. Glass AG, Hoover RN (1989) The emerging epidemic of melanoma and squamous cell cancer. JAMA 262: 2097–2100PubMedCrossRefGoogle Scholar
  11. Green AES (1978) Ultraviolet exposure and skin cancer response. Am J Epidemiol 107: 277–280PubMedGoogle Scholar
  12. Holman CDJ, James IR, Gattey PH, Armstrong BK (1980) An analysis of trends in mortality from malignant melanoma of the skin in Australia. Int J Cancer 26: 703–709PubMedCrossRefGoogle Scholar
  13. Karjalainen S, Hakulinen T (1988) Survival and prognostic factors of patients with skin melanoma. Cancer 62: 2274–2280PubMedCrossRefGoogle Scholar
  14. Lee JAH (1991) Trends in melanoma incidence and mortality. Clin Dermatol (in press)Google Scholar
  15. Lemish WM, Heenan PJ, Holman CDJ, Armstrong BK (1983) Survival from preinvasive and invasive malignant melanoma in Western Australia. Cancer 52: 580–585PubMedCrossRefGoogle Scholar
  16. Lindegard B (1990) Mortality and fatality of cutaneous malignant melanoma in Sweden, 1982–1986. Biomed Pharmacother 44: 495–501PubMedCrossRefGoogle Scholar
  17. Longstreth JD (1987) Ultraviolet radiation and melanoma. With a special focus on assessing the risks of stratospheric ozone depletion. US Environmental Protection Agency, Washington, DCGoogle Scholar
  18. Muir CS, Nectoux J (1982) Time trends: malignant melanoma of the skin. In: Magnus K (ed.) Trends in cancer incidence. Hemisphere Publishing Corporation, Washington, pp 365–385Google Scholar
  19. Nordlund JJ, Kirkwood J, Forget BM et al. (1985) Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 45: 1855–1861PubMedGoogle Scholar
  20. Osterlind A. (1987) Trends in incidence of ocular malignant melanoma in Denmark, 1943–1982 Int J Cancer 40: 161–164Google Scholar
  21. Osterlind A (1990) Malignant melanoma in Denmark: occurrence and risk factors. Acta Oncol 29: 833–853PubMedCrossRefGoogle Scholar
  22. Osterlind A, Tucker MA, Stone BJ. (1988a) The Danish case-control control study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int J Cancer 42: 319–324Google Scholar
  23. Osterlind A, Hou-Jensen K, Jensen OM (1988b) Incidence of cutaneous malignant melanoma in Denmark, 1978–1982. Atomic site distribution, histologic types, and comparisons with nonmelanoma skin cancer. Br J Cancer 58: 385–391Google Scholar
  24. Osterlind A, Engholm G, Jensen OM (1988c) Trends in cutaneous malignant melanoma in Denmark, 1943–1982, by anatomic site. APMIS 1988c; 96: 953–963CrossRefGoogle Scholar
  25. Reilly WK, Administrator, US Environmental Protection Agency (1991) Text of Public Statement: AprilGoogle Scholar
  26. Roush GC, Schymura MJ, Holford TR (1985) Risk for cutaneous melanoma in recent Connecticut birth cohorts. Am J Public Health 75: 679–682PubMedCrossRefGoogle Scholar
  27. Schneider JS, Sagebiel RW, Moore II DH, Lawton GM (1987) Melanoma surveillance and earlier diagnosis. Lancet i: 1435Google Scholar
  28. Schultz S, Kane M, Roush R et al. (1990) Time to recurrence varies inversely with thickness in clinical stage 1 cutaneous melanoma. Surg Gynecol Obstet 171: 393–397PubMedGoogle Scholar
  29. Scotto, J, Cotton G, Urbach F et al. (1987) Biologically effective ultra-violet radiation: surface measurements in the United States, 1974 to 1985. Science 239: 762–764CrossRefGoogle Scholar
  30. Scotto J, Pitcher H, Lee JAH (1991) Indications of decreasing trends in skin melanoma risks among whites in the United States. Int J Cancer 49: 1–7CrossRefGoogle Scholar
  31. Strickland D, Lee JAH (1981) Melanomas of the eye: stability of rates. Am J Epidemiol 113: 700–702PubMedGoogle Scholar
  32. Thorn M, Adami H-O, Bergstrom R et al. (1989) Trends in survival from malignant melanoma: remarkable improvement in 23 years. J Natl Cancer Inst 81: 611–617PubMedCrossRefGoogle Scholar
  33. van der Esch EP, Muir CS, Nectoux J et al. (1991) Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 47: 483–490PubMedCrossRefGoogle Scholar
  34. Venzon DJ, Moolgavkar SH (1984) Cohort analysis of malignant melanoma in five countries. Am J Epidemiol 119: 62–70PubMedGoogle Scholar
  35. Weinstock MA, Colditz GA, Willett WC et al. (1991) Recall (report) bias and reliability in the retrospective assessment of melanoma risk. Am J Epidemiol 133: 240–245PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 1992

Authors and Affiliations

  • J. A. H. Lee

There are no affiliations available

Personalised recommendations